BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12422546)

  • 1. [Cardiotoxicity of 5-fluorouracil: report of 6 cases].
    Timour Q; Lombard-Bohas C; Slim R; Barel C; Bui-Xuan B; Tabib A; Bricca G; Malonne H; Vial T; Iordescu D; Descotes J
    Therapie; 2002; 57(3):302-6. PubMed ID: 12422546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease.
    Tsibiribi P; Descotes J; Lombard-Bohas C; Barel C; Bui-Xuan B; Belkhiria M; Tabib A; Timour Q
    Bull Cancer; 2006 Mar; 93(3):E27-30. PubMed ID: 16567310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
    Tsavaris N; Kosmas C; Vadiaka M; Efremidis M; Zinelis A; Beldecos D; Sakelariou D; Koufos C; Stamatelos G
    Med Sci Monit; 2002 Jun; 8(6):PI51-7. PubMed ID: 12070449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiotoxicity induced by 5-fluorouracil. Review of the literature].
    Blázquez Encinar JC; Martín Jiménez M; Díaz-Rubio García E; Almenarez J
    Rev Clin Esp; 1989 Mar; 184(5):249-51. PubMed ID: 2672149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotoxicity of 5-fluorouracil.
    Collins C; Weiden PL
    Cancer Treat Rep; 1987; 71(7-8):733-6. PubMed ID: 3300968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiotoxicity of 5-fluorouracil: coronary spasm? Apropos of 2 cases with normal coronarography].
    Cristofini P; Desnos M; Guenot O; Funck F; Hagege A; Trotoux J; Guerot C
    Ann Med Interne (Paris); 1989; 140(1):9-13. PubMed ID: 2660665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiotoxicity of continuous intravenous infusion of 5-fluorouracil: clinical study, prevention and physiopathology. Apropos of 13 cases].
    de Forni M; Bugat R; Sorbette F; Delay M; Bachaud JM; Chevreau C
    Bull Cancer; 1990; 77(5):429-38. PubMed ID: 2205312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic cardiotoxicity associated with 5-fluorouracil.
    Meyer CC; Calis KA; Burke LB; Walawander CA; Grasela TH
    Pharmacotherapy; 1997; 17(4):729-36. PubMed ID: 9250550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiotoxicity of 5-fluorouracil. Clinical picture of 4 cases and a prevention proposal].
    Bourgeois H; Perault MC; Raud-Raynier P; Favrelière S; Daban A; Vandel B
    Therapie; 1993; 48(3):255-8. PubMed ID: 8140566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiotoxicity of 5-fluorouracil].
    Pan L; Yang X; Song H
    Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):86-9. PubMed ID: 8758800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute heart failure after treatment with 5-fluorouracil.
    Georgieva S; Kinova E; Iordanov V; Gudev A; Tzekova V; Velikova M
    J BUON; 2007; 12(1):113-6. PubMed ID: 17436411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of preventing 5-fluorouracil cardiotoxicity by prophylactic treatment with verapamil.
    Eskilsson J; Albertsson M
    Acta Oncol; 1990; 29(8):1001-3. PubMed ID: 2278719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1 and 5-fluorouracil-induced cardiotoxicity.
    Porta C; Moroni M; Ferrari S; Nastasi G
    Neoplasma; 1998; 45(2):81-2. PubMed ID: 9687887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [5-fluorouracil: cause of a fatal myocardial infarction in combined radiochemotherapy?].
    Maurer U; Härle M; Jungius KP
    Strahlenther Onkol; 1996 May; 172(5):257-9. PubMed ID: 8633257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiac toxicity of fluoro-uracil. Typical and atypical aspects. Apropos of 8 cases].
    Ferrari E; Taillan B; Tibi T; Darmon JP; Gibelin P; Chichmanian RM; Dujardin P; Morand P
    Ann Cardiol Angeiol (Paris); 1992 Apr; 41(4):191-5. PubMed ID: 1642435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.
    Cianci G; Morelli MF; Cannita K; Morese R; Ricevuto E; Di Rocco ZC; Porzio G; Lanfiuti Baldi P; Ficorella C
    Br J Cancer; 2003 May; 88(10):1507-9. PubMed ID: 12771913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiotoxicity of 5-fluorouracil].
    Teixeira L; Barry S; Debourdeau P; Cohen A; Tournigand C
    Bull Cancer; 2004 Nov; 91 Suppl 3():154-8. PubMed ID: 15899622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of patients with persistent chest pain and ST-segment elevation during 5-fluorouracil treatment: report about two cases.
    Mafrici A; Alberti A; Corrada E; Ferrari S; Marenna B
    Ital Heart J; 2003 Dec; 4(12):895-9. PubMed ID: 14976858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiotoxicity of de Gramont's regimen: incidence, clinical characteristics and long-term follow-up.
    Meydan N; Kundak I; Yavuzsen T; Oztop I; Barutca S; Yilmaz U; Alakavuklar MN
    Jpn J Clin Oncol; 2005 May; 35(5):265-70. PubMed ID: 15855175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.